Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of AngioDynamics, Inc. (“AngioDynamics” or the “Company”) (NASDAQ:ANGO) concerning possible violations of federal securities laws. The investigation focuses on allegations that certain statements issued by the Company between October 9, 2014 and April 9, 2015, regarding AngioDynamics’ business, operations and prospects were false or misleading.

AngioDynamics is a provider of minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. The investigation relates to the Company’s April 9, 2015 announcement of its financial results for the third quarter 2015. The Company reported a quarterly loss of $4.3 million and revised its net sales outlook for the 2015 fiscal year to a range of $356 million to $360 million from its prior outlook of a range of $362 million to $368 million. On this news, the Company’s stock declined by as much as 8% on heavy volume.

If you purchased AngioDynamics shares during the relevant period, if you have information or would like to learn more about these claims, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.